MEDINOV Relative Valuation - Medinova Diagnostic Services Ltd

Watchlist Manager

Watchlist

Price: 43.45 INR -1.27% Market Closed

Market Cap: ₹433.6m

	Medinova Diagnostic Services Ltd BSE:526301	IN

Multiples-Based Value

526301 doesn't have a meaningful market cap.

The Multiples-Based Value of one MEDINOV stock under the Base Case scenario is 48.22 INR. Compared to the current market price of 43.45 INR, Medinova Diagnostic Services Ltd is Undervalued by 10%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

MEDINOV Multiples-Based Value

Base Case

Undervaluation 10%

Multiples-Based Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
IN		Medinova Diagnostic Services Ltd BSE:526301	433.7m INR	4.3	20.3	13.4	14
US		CVS Health Corp NYSE:CVS	90.5B USD	0.2	50.4	13.3	13.3
US	C	Cigna Group XMUN:CGN	68B EUR	0.3	13.4	7.8	9.9
US		Cigna Corp NYSE:CI	71.7B USD	0.3	11.6	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.8B EUR	1.1	19.5	9.3	13.8
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.2	23.3	9	16.6
US		Laboratory Corporation of America Holdings NYSE:LH	22.1B USD	1.6	24.8	11.9	17.3
US		Quest Diagnostics Inc NYSE:DGX	21.8B USD	1.9	21.8	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9B EUR	0.5	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	11.5B USD	11.3	-26.6	-29.1	-26.4
US		DaVita Inc NYSE:DVA	10.7B USD	0.8	14.2	7.3	9.8

				Revenue Growth	P/S to Growth
IN		Medinova Diagnostic Services Ltd BSE:526301	Average P/S: 2.1 4.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
IN		Medinova Diagnostic Services Ltd BSE:526301	Average P/E: 21 20.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	50.4	90%	0.6
US	C	Cigna Group XMUN:CGN	13.4	19%	0.7
US		Cigna Corp NYSE:CI	11.6	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.5	26%	0.7
DE		Fresenius Medical Care AG XMUN:FME	23.3	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	24.8	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.6	N/A	N/A
US		DaVita Inc NYSE:DVA	14.2	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
IN		Medinova Diagnostic Services Ltd BSE:526301	Average EV/EBITDA: 9.9 13.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.9	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.1	N/A	N/A
US		DaVita Inc NYSE:DVA	7.3	4%	1.8

				EBIT Growth	EV/EBIT to Growth
IN		Medinova Diagnostic Services Ltd BSE:526301	Average EV/EBIT: 13.4 14	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	22%	0.6
US	C	Cigna Group XMUN:CGN	9.9	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.8	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.6	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.3	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.4	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Medinova Diagnostic Services Ltd
BSE:526301

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

MEDINOV Competitors Multiples
Medinova Diagnostic Services Ltd Competitors

See Also

Company

Help

Tools

Stocks

Medinova Diagnostic Services Ltd BSE:526301

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

MEDINOV Competitors Multiples Medinova Diagnostic Services Ltd Competitors

See Also

Company

Help

Tools

Stocks

Medinova Diagnostic Services Ltd
BSE:526301

MEDINOV Competitors Multiples
Medinova Diagnostic Services Ltd Competitors